Frequency of adverse events and mortality in patients with pleural empyema in a public referral hospital in Mexico City

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 9, 2010, Pages 1187-1192

  Herrera Kiengelher, L ^a   Baez Saldana R ^a   Salas Hernandez J ^a   Avalos Bracho, A ^a   Perez Padilla R ^a   Torre Bouscoulet, L ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Adverse event; Empyema; Epidemiology; Lung infection; Pneumonia

Indexed keywords

ADULT; ADVERSE OUTCOME; ALCOHOLISM; ARTICLE; COMORBIDITY; DECORTICATION; DIABETES MELLITUS; DISABILITY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; PLEURA EMPYEMA; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PUBLIC HOSPITAL; RISK FACTOR; SOCIAL STATUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THORACOCENTESIS; THORACOSCOPY;

ADULT; EMPYEMA, PLEURAL; FEMALE; HOSPITAL MORTALITY; HOSPITALS, PUBLIC; HUMANS; LENGTH OF STAY; MALE; MEXICO; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77956590885     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322: 517-519. (Pubitemid 32230913)
2. Institute of Medicine. To err is human. Building a safer health system. Washington DC, USA: National Academy Press, 2000.
3. Herrera-Kiengelher L, Chi-Lem G, Baez-Saldana R, et al. Frequency and correlates of adverse events in a respiratory diseases hospital in Mexico City. Chest 2005; 128: 3900-3905.
4. Molnar T F. Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg 2007; 32: 422-430.
5. Kretschmer R, Pérez T R. La estructura de la práctica médica actual en el ejercicio actual de la medicina. Editorial Siglo XXI. Universidad Nacional Autónoma de México, 2000. [Spanish]
6. Brennan T A, Leape L L, Laird N M, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991; 324: 370-376.
7. Coote N, Kay E. Surgical versus non-surgical management of pleural empyema. Cochrane Database Syst Rev 2005: CD001956.
8. LeMense G P, Strange C, Sahn S A. Empyema thoracis. Therapeutic management and outcome. Chest 1995; 107: 1532-1537.
9. Hampson C, Lemos J A, Klein J S. Diagnosis and management of parapneumonic effusions. Semin Respir Crit Care Med 2008; 29: 414-426.
10. Rahman N M, Chapman S J, Davies R J. The approach to the patient with a parapneumonic effusion. Clin Chest Med 2006; 27: 253-266.
11. Gates R L, Caniano D A, Hayes J R, et al. Does VATS provide optimal treatment of empyema in children? A systematic review. J Pediatr Surg 2004; 39: 381-386.
12. Light R W. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006; 3: 75-80.
13. Solaini L, Prusciano F, Bagioni P. Video-assisted thoracic surgery in the treatment of pleural empyema. Surg Endosc 2007; 21: 280-284.
14. Wurnig P N, Wittmer V, Pridun N S, et al. Video-assisted thoracic surgery for pleural empyema. Ann Thorac Surg 2006; 81: 309-313.
15. Cameron R, Davies H R. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2008: CD002312.